Talk:Breast cancer–related regulator of tp53
Latest comment: 3 years ago by Usernamekiran in topic Requested move 24 July 2020
 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||
| ||||||||||||||||||||||||
 | On 24 July 2020, it was proposed that this article be moved from Breast cancer-related regulator of tp53 to Breast cancer–related regulator of tp53. The result of the discussion was moved. |
Requested move 24 July 2020 edit
- The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.
The result of the move request was: moved per MOS:SUFFIXDASH, and consistency with other articles. —usernamekiran (talk) 09:43, 5 August 2020 (UTC)
- Breast cancer-related regulator of tp53 → Breast cancer–related regulator of tp53
- Critical illness-related corticosteroid insufficiency → Critical illness–related corticosteroid insufficiency
- Cystic fibrosis-related diabetes → Cystic fibrosis–related diabetes
- HIV disease-related drug reaction → HIV disease–related drug reaction
- Urotensin II-related peptide → Urotensin II–related peptide
- Xenotropic murine leukemia virus-related virus → Xenotropic murine leukemia virus–related virus
– Per MOS:SUFFIXDASH and the recent RMs at Talk:Index of Ascension Island–related articles, Talk:Middle East respiratory syndrome–related coronavirus, and Talk:Severe acute respiratory syndrome–related coronavirus. —BarrelProof (talk) 01:37, 24 July 2020 (UTC)
- The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.